Pharma IQ Members

Follow-on Biologics

-

Improving the Security, Quality & Compliance of your Biologic Operation

In the coming years, biologics are expected to make up a greater proportion of revenue growth for pharmaceutical companies, with some figures placing it as high as 60 per cent.  The US Food and Drug Administration last year approved a total of 24...

Contributor: Pharma IQ
Mon, 02/20/2012
Pharma IQ

It was only matter of time before the United States Food and Drug Administration (FDA) put in place guidance for the marketing of biosimiliars – and it would seem that time is almost upon us. Global spending on biosimilars is expected to reach $2...

Contributor: Pharma IQ
Tue, 05/17/2011
Pharma IQ

Pharma IQ chats with Eileen Edmonson, Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, about navigating the U.S. Department of Transportation’s regulations for biologics and biological agents.

Contributor: Pharma IQ
Tue, 04/20/2010